用户验证的应用
经验证应用
| 项目 | 详情 |
|---|---|
| ICC | Immunocytochemistry analysis of Hela cells labeling Notch 1 with Notch 1 antibody ( HY-P80426 ) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Notch 1 antibody ( HY-P80426 ) at 1/50 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue). Immunocytochemistry analysis of NIH3T3cells labeling Notch 1 with Notch 1 antibody ( HY-P80426 ) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, then blocked with QuickBlock™ Blocking Buffer for Immunol Staining for 10 min at room temperature. Cells were then incubated with Notch 1 antibody ( HY-P80426 ) at 1/50 dilution in QuickBlock™ Blocking Buffer for Immunol Staining at 4 ℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue). |
| WB | Western blot analysis of extracts from THP-1(lane 2(20μg)), HeLa(lane 3(20μg)) and C6(lane 4(40μg)) using Notch 1 ( HY-P80426 ) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% BSA in TBST at 4°C overnight. Goat Anti-Rabbit IgG-HRP Secondary Antibody (1/10,000) was used for 1 hour at room temperature. |
| IHC-P | Immunohistochemical analysis of paraffin-embedded Mouse lung tissue using Notch 1 Antibody. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked in QuickBlock for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HY-P80426, 1/100) in 4℃ overnight. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. |
推荐稀释比例
- WB1:1000-1:2000
- ICC/IF1:50-1:200
- IHC-P1:50-1:200
- FC1:50-1:100
- IPUse at an assay dependent concentration.
详细信息
背景信息
功能: Notch1 作为膜结合配体 Jagged-1 (JAG1)、Jagged-2 (JAG2) 和 Delta-1 (DLL1) 的受体,调控细胞命运决定。配体激活后,释放的 Notch 胞内结构域 (NICD) 与 RBPJ/RBPSUH 形成转录激活复合物,激活分裂增强子基因座的基因,影响分化、增殖和凋亡程序的执行。它参与血管生成,负调控内皮细胞的增殖、迁移以及血管出芽。它还参与胸腺中 CD4 (+) 和 CD8 (+) 细胞的成熟,对滤泡分化以及滤泡内的细胞命运选择可能具有重要作用。在小脑发育过程中,它作为神经元 DNER 的受体,参与伯格曼胶质细胞的分化,抑制神经元和成肌分化。它可能在植入后发育中发挥关键作用,大概率参与细胞特化和/或分化的某些环节,还可能参与中胚层发育、体节形成和神经发生。它可通过将 HIF1AN 与 HIF1A 隔离,增强 HIF1A 的功能。损伤后,THBS4 调控室管膜下区 (SVZ) 微环境的保护性星形胶质细胞生成的过程需要 Notch1 参与。它还通过调节左右组织者 (LRO) 中运动纤毛和非运动 (感觉) 纤毛的平衡,参与左右对称性的决定。 亚细胞定位: 细胞膜;单次跨膜 I 型膜蛋白;晚期内体膜;单次跨膜 I 型膜蛋白;细胞核 表达水平: 组织特异性:在胎儿组织中,脾脏、脑干和肺脏含量最为丰富。在大多数人组织中也有分布,主要存在于淋巴组织中。 亚基: NOTCH1 的 C 端片段 N (TM) 和 N 端片段 N (EC) 可能通过二硫键连接形成异二聚体。NOTCH1 与 DNER、DTX1、DTX2 和 RBPJ/RBPSUH 相互作用。NOTCH1 还与 MAML1、MAML2 和 MAML3 相互作用,这些分子作为 NOTCH1 的转录共激活因子发挥作用 (PubMed:11101851, PubMed:12370315)。NOTCH1 的胞内结构域与 SNW1 相互作用;这种相互作用涉及多聚化的 NOTCH1 NICD,并参与中间预激活复合物的形成,该复合物与 DNA 结合的 CBF-1/RBPJ 结合 (PubMed:10713164)。激活的膜结合形式与 AAK1 相互作用,从而促进 NOTCH1 的稳定。NOTCH1 与 FBXW7 和 SGK1 形成三聚体复合物。NOTCH1 与 HIF1AN 相互作用。 HIF1AN 负调控 Notch 胞内结构域 (NICD) 的功能,加速肌源性分化 (PubMed:17573339)。HIF1AN 通过 NICD 与 SNAI1 相互作用 (通过锌指结构域);这种相互作用诱导 SNAI1 通过 MDM2 介导的泛素化降解,并抑制 SNAI1 诱导的细胞侵袭。HIF1AN 通过 NICD 与 MDM2A 相互作用。HIF1AN 通过 NICD 与 BCL6 相互作用;这种相互作用降低 NOTCH1 NICD 在靶基因 DNA 上募集 MAML1 的能力,并抑制 NOTCH1 的转录激活活性。HIF1AN 通过结构相似性与 THBS4 相互作用。HIF1AN 通过 EGF 样重复序列与 CCN3 相互作用 (通过 CTCK 结构域)(PubMed:12050162)。HIF1AN 通过 EGF 样结构域与 DLL4 相互作用 (通过 N 端 DSL 和 MNNL 结构域)(通过结构相似性)。与 ZMIZ1 相互作用。通过 NICD 结构域与 MEGF10 相互作用 (通过胞质结构域)。与 DLL1 和 JAG1 相互作用 (基于相似性)。通过 NICD 结构域与 PRAG1 相互作用 (基于相似性)。以 MAML1 依赖的方式与 PRAG1、N1ICD 和 MAML1 形成复合物 (基于相似性)。通过跨膜区与 PSEN1 相互作用;该相互作用是直接的 (PubMed:30598546)。与 ZFP64 相互作用 (基于相似性)。